Document is current
Any future updates will be listed below
-
Authors
García-Escobar, E.
Valdés, S.
Soriguer, F.
Vendrell, J.
Urrutia-Etxebarria, I. M.
Maldonado-Araque, C.
Ortega, E.
Ocón, P.
Montanya, E.
Menéndez, E.
Lago-Sampedro, A.
González-Frutos, T.
Gomis, R.
Goday, A.
García-Serrano, S.
Galán-García, J. L.
Castell, C.
Bordiú, E.
Badía, R.
Aguilera-Venegas, G.
Girbés, J.
Gaztambide, S.
Delgado, E.
Chaves, F. J.
Castaño, L.
Calle-Pascual, A.
Rojo-Martínez, G.
Franch-Nadal, J.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CM19/00186)
Consejería de Salud y Familias, Junta de Andalucía (C-0060-2012)
- License Information
-
More Information
Article History
Received: 20 January 2021
Accepted: 20 July 2021
First Online: 12 August 2021
Competing interests
: Eduard Montanya has been on advisory boards, has received consulting fees, speaker honoraria or research support from Astra Zeneca, Menarini Laboratories, Merck Sharp & Dohme, Novartis, NovoNordisk and Sanofi. None of the other authors declare having financial or not financial competing interests, related to this work.
